In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia.
An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the final say on the committee’s recommendations and could decide within weeks.
Doctors already have given their verdict. Avandia prescriptions have plummeted since a study in The New England Journal of Medicine in May 2007 raised concerns about whether the drug increased heart attack risk.
Dallas Fort Worth Injury Lawyer Blog


